The Pharmacology of Anabolic-Androgen Steroids

  • Norman S. Miller


The anabolic-androgen steroids (AAS) are chemicals that have both properties contained in the same molecule. Therefore, it is impossible to discuss one type of action without including the other because the effects of intoxication from these compounds are both anabolic and androgenic. Anabolic action is the performance-enhancing and muscle-mass-proliferation property, whereas the androgenic action is characteristic of male sex hormones. The pharmacological objective in use by athletes is to promote the anabolic or performance-enhancing effect while attempting to minimize the androgenic effect.


Anabolic Steroid Weight Lifter Steroid User Testosterone Propionate Testosterone Enanthate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Redda KK, Walker CA, Barnett G (1989). Cocaine, Marijuana, Designer Drugs: Chemistry, Pharmacology and Behavior. Boca Raton, FL: CRC Press.Google Scholar
  2. 2.
    Haupt HA, Rovere GD (1984). Anabolic steroids: A review of the literature. Am J Sports Med12:469–484.PubMedCrossRefGoogle Scholar
  3. 3.
    Kochakian CD, Murlin JR (1935). The effect of male hormone on problem and energy metabolism of castrated dogs. J Nutr10:437.Google Scholar
  4. 4.
    Kopera H (1985). The history of anabolic steroids and a review of clinical experience with anabolic steroids. Acta Endocrinol (Suppl)271:11–18.Google Scholar
  5. 5.
    Wilson JD (1988). Androgen abuse by athletes. Endocrinol Rev9:181–199.CrossRefGoogle Scholar
  6. 6.
    Lamb DR (1984). Anabolic steroids in athletics: How well do they work and how dangerous are they? Am J Sports Med12:31–38.CrossRefGoogle Scholar
  7. 7.
    Murad F, Haynes RC (1985). Androgens. In The Pharmacological Basis of Therapeutics, Gilman AG, Goodman LS, Rail TW, Murad F, eds. New York: Macmillan.Google Scholar
  8. 8.
    Rogers HJ, Spector RG, Trounce JR (1981). A Textbook of Clinical Pharmacology. London: Hodder and Stoughton.Google Scholar
  9. 9.
    Council on Scientific Affairs (1988). Drug abuse in athletes: Anabolic steroids and human growth hormone. JAMA259:1703–1705.CrossRefGoogle Scholar
  10. 10.
    Buckley WE, Yesalis CE, Friedl K, et al. (1988). Estimated prevalence of anabolic steroid use among male high school seniors. JAMA260:3441–3445.PubMedCrossRefGoogle Scholar
  11. 11.
    Dezelsky TL, Toohey JV, Shaw RS (1985). Non-medical drug use behavior at five United States universities: 1 15-year study. Bull Narc37 (2–3): 49–53.PubMedGoogle Scholar
  12. 12.
    Coward V (1987). Steroids in sports: After four decades, time to return these genies to bottle? JAMA257:421–427.CrossRefGoogle Scholar
  13. 13.
    Bergman R, Leach RE (1985). The use and abuse of anabolic steroids in Olympic-caliber athletes. Clin Orthop Relat Res198:169–172.PubMedGoogle Scholar
  14. 14.
    Frankle MA, Cicero GJ, Payne J (1984). Use of androgenic anabolic steroids by athletes. JAMA252:482.PubMedCrossRefGoogle Scholar
  15. 15.
    Pope HG Jr, Katz DL, Champoux R (1988). Anabolic-androgenic steroid use among 1,010 college men. Physician Sportsmed16:75–81.Google Scholar
  16. 16.
    Pope HG Jr, Katz DL (1988). Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry145: 487–490.PubMedGoogle Scholar
  17. 17.
    Gower DB (1979). Steroid Hormones. London: Croom Helm.Google Scholar
  18. 18.
    Van Wayjen RGA, Buyze G (1962). Clinical pharmacological evaluation of certain anabolic steroids. Acta Endocrinol (Suppl)63:18.Google Scholar
  19. 19.
    Griffin JE, Wilson JD (1985). Disorders of the testes and male reproductive tract. In Textbook of Endocrinology, Wilson JD, Foster DW, eds., pp. 259–311. Philadelphia: Saunders.Google Scholar
  20. 20.
    Desauller PA, Krahenbhl C (1962). Evaluation and mode of action of anabolic steroids: Differentiation of action of various anabolic steroids. In Protein Metabolism, p. 185. Berlin: Springer-Verlag.Google Scholar
  21. 21.
    Smith RG, Nag A, Syms AL, Norris JSH (1986). Steroid receptor, gene structure and molecular biology. J Steroid Biochem214:51.CrossRefGoogle Scholar
  22. 22.
    Tepperman J (1973). Metabolic and Endocrine Physiology, p. 70. Chicago: Yearbook Medical Publisher.Google Scholar
  23. 23.
    Nowakowski H (1962). Metabolic studies with anabolic steroids. Acta Endocrinol (Suppl)63:37.Google Scholar
  24. 24.
    Kibble MW, Ross MB (1987). Adverse effects of anabolic steroids in athletes. Clin Pharm6:686–692.PubMedGoogle Scholar
  25. 25.
    McNutt RA, Ferenchick GS, Kirlin PC, et al. (1988). Acute myocardial infarction in a 22-year-old world-class weight lifter using anabolic steroids. Am J Cardiol62:164.PubMedCrossRefGoogle Scholar
  26. 26.
    Mochizuki RH, Richter KJ (1988). Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Physician Sportsmed16:109–114.Google Scholar
  27. 27.
    Ishak KG, Zimmerman HJ (1987). Hepatotoxic effects of the anabolic/andro-genic steroids. Semin Liver Dis7:230–236.PubMedCrossRefGoogle Scholar
  28. 28.
    Creagh TM, Rubin A, Evans DJ (1988). Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol 41.-441–443.Google Scholar
  29. 29.
    APA (1987). DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, Washington, DC: American Psychiatric Association.Google Scholar
  30. 30.
    Brower KJ, Blow FC, Beresford TP, Fuelling C (1989). Anabolic-androgenic steroid dependence. J Clin Psychiatry50:31–33.PubMedGoogle Scholar
  31. 31.
    Hatton CK, Catlin DH (1987). Detection of androgenic anabolic steroids in urine. Clin Lab Med7:655–668.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York 1991

Authors and Affiliations

  • Norman S. Miller
    • 1
  1. 1.Cornell University Medical CollegeNew York Hospital-Cornell Medical CenterUSA

Personalised recommendations